alfarix
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Jul 1, 2002 (NCT00221676)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- alfarix
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00221676 | Phase 4 | Jul 1, 2002 | Eurogenerics NV, University of Antwerp |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eurogenerics NV | For profit | 1 | 0 | 1 | 2002 |
| University of Antwerp | Academic/Hospital | 1 | 1 | 1 | 2002 |
2 organizations
Page 1 / 1